Glimcher, Laurie Hollis
- Dana-Farber Cancer Institute (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #134
- Top 1% Funded
- Sustained Excellence
- Program Leader
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$13.8M
Full award amounts, FY2023
Award Records
6
Records listing this PI
Award-Linked Rank
#134
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Glimcher, Laurie Hollis as a PI. Multi-PI records show the full award amount for context.
- $12.7Maward amount
- 3P30CA006516-58S4P30Contact PIReal-World Molecularly Targeted Treatment Registry (MaTTeR): a Pilot Study to Enrich CCDI Data Utilizing Directed Electronic Medical Record (EMR) Extraction$495.9Kaward amount
- 3P30CA006516-58S2P30Contact PIDeveloping a pragmatic guide to implementing social risk referrals: A partnership between Caring Health Center (CHC) and the Implementation Science Center for Cancer$224.7Kaward amount
- 3P30CA006516-58S1P30Contact PIAdministrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP)$208.8Kaward amount
- 3P30CA006516-58S3P30Contact PIUnderstanding the impact of an EHR-integrated hereditary cancer risk assessment application on patient-provider communication$100Kaward amount
- 5R03CA262839-02R03Contact PIRepurposing Bruton's tyrosine kinase (BTK) inhibitors to reverse immunosuppression in high-grade serous ovarian cancer (HGSC)$89Kaward amount
Award organization
Organizations that administered FY2023 awards listing Glimcher, Laurie Hollis as a PI.
FY2023 award administered by Dana-Farber Cancer Institute (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardDana-Farber Cancer Institute
- 2006$500K Cumulative Funding
- 2006$1M Cumulative Funding
- 2006$2M Cumulative Funding
- 2006$5M Cumulative Funding
- 2006Entered Top 50% NationallyRanked #255
- 2006Entered Top 25% NationallyRanked #255
- 2006Entered Top 10% NationallyRanked #255
- 2006Entered Top 5% NationallyRanked #255
- 2007$10M Cumulative Funding
- 2014Program/Center Grant Leader
- 2017$25M Cumulative Funding
- 2017Entered Top 1% NationallyRanked #108
- 2019$50M Cumulative Funding
- 2023$100M Cumulative Funding